Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

Multiple Cancer Types

This is a Phase I multicenter, open label, nonrandomized study of enadenotucirev administered in combination with nivolumab in subjects with metastatic or advanced epithelial tumors (with focus on CRC, SCCHN, escalation phase), not responding to standard therapy.
Colon, Head/Neck, Lung, Non Small Cell, Rectal, Urologic
I/II
Berlin, Jordan
NCT02636036
VICCMD1762

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: